Getting Low in Familial Hypercholesterolemia Getting Low in Familial Hypercholesterolemia

Getting Low in Familial Hypercholesterolemia

Reducing LDL-C and a Lifetime of Cardiovascular Risk

Publisher Description

FH is marked by high levels of circulating LDL-C, leading to increased risk of premature atherosclerotic cardiovascular disease (ASCVD). Patients frequently remain undiagnosed, resulting in poor outcomes and failure to diagnose family members. Clinicians should be aware of the diagnostic criteria as well as the importance of genetic testing. FH generally responds inadequately to traditional lipid-lowering therapies such as statins and often necessitates more effective biologic therapies. A multidisciplinary approach is needed in treating FH, and clinicians should be aware of recent discoveries in lipid genetics, currently endorsed diagnostic criteria, and recently approved and emerging agents to treat FH.

GENRE
Professional & Technical
RELEASED
2021
December 15
LANGUAGE
EN
English
LENGTH
49
Pages
PUBLISHER
Integritas Communicatoins
SELLER
Integritas Communications
SIZE
101.9
MB

More Books Like This

Medifocus Guidebook on Medifocus Guidebook on
2011
Multiple Lipoprotein Abnormalities Associated with Insulin Resistance in Healthy Volunteers are Identified by the Vertical Auto Profile-Ii Methodology (Technical Briefs) Multiple Lipoprotein Abnormalities Associated with Insulin Resistance in Healthy Volunteers are Identified by the Vertical Auto Profile-Ii Methodology (Technical Briefs)
2003
Enhanced Susceptibility to Oxidation and Diminished Vitamin E Content of LDL from Patients with Stable Coronary Artery Disease (Lipids, Lipoproteins, And Cardiovascular Risk Factors) Enhanced Susceptibility to Oxidation and Diminished Vitamin E Content of LDL from Patients with Stable Coronary Artery Disease (Lipids, Lipoproteins, And Cardiovascular Risk Factors)
2001
Estimating LDL Apob: Infomania Or Clinical Advance?(Editorial) (Clinical Report) Estimating LDL Apob: Infomania Or Clinical Advance?(Editorial) (Clinical Report)
2008
Influence of Folic Acid on Plasma Homocysteine Levels & Arterial Endothelial Function in Patients with Unstable Angina (Report) Influence of Folic Acid on Plasma Homocysteine Levels & Arterial Endothelial Function in Patients with Unstable Angina (Report)
2009
Relationship Among Plasma Secretory Phospholipase [a.Sub.2], Oxidized Low Density Lipoprotein & Paraoxonase Activities in Hypertensive Subjects Treated with Angiotensin Converting Enzyme Inhibitors (Report) Relationship Among Plasma Secretory Phospholipase [a.Sub.2], Oxidized Low Density Lipoprotein & Paraoxonase Activities in Hypertensive Subjects Treated with Angiotensin Converting Enzyme Inhibitors (Report)
2009